Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt flag Egypt · Delayed Price · Currency is EGP
4.620
-0.030 (-0.65%)
At close: Apr 23, 2026
Market Cap9.24B +39.0%
Revenue (ttm)4.10B +47.9%
Net Income268.61M -23.0%
EPS0.13 -26.2%
Shares Out2.00B
PE Ratio34.58
Forward PE14.97
Dividend0.04 (0.87%)
Ex-Dividend Daten/a
Volume7,205,191
Average Volume15,318,766
Open4.650
Previous Close4.650
Day's Range4.580 - 4.690
52-Week Range3.022 - 5.120
Beta0.36
RSI64.62
Earnings DateMay 14, 2026

About EGX:RMDA

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E), together with its subsidiaries, produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt. The company manufactures, markets, sells, and stores pharmaceutical reagents for human and veterinary use, and diagnostic reagents for individuals, laboratories, and hospitals; imports pharmaceutical reagents and raw materials; and produces food supplements for human use. It offers a portfolio of ... [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol RMDA
Full Company Profile

Financial Performance

In 2025, EGX:RMDA's revenue was 4.10 billion, an increase of 47.94% compared to the previous year's 2.77 billion. Earnings were 268.61 million, a decrease of -26.17%.

Financial Statements